EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
DexCom, Inc. (DXCM) had EBITDA Margin of 20.28% for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
$4.03B |
|
$576.20M |
|
$1.59B |
|
$2.44B |
|
$3.43B |
|
$600.00M |
|
$109.00M |
|
$709.00M |
|
$709.00M |
|
$576.20M |
|
$576.20M |
|
$576.20M |
|
$576.20M |
|
$600.00M |
|
$817.70M |
|
393.60M |
|
412.70M |
|
$1.46 |
|
$1.42 |
|
Balance Sheet Financials | |
$4.30B |
|
$1.34B |
|
$2.18B |
|
$6.48B |
|
$2.93B |
|
$1.24B |
|
$1.45B |
|
$4.38B |
|
$2.10B |
|
$1.98B |
|
$2.10B |
|
390.70M |
|
Cash Flow Statement Financials | |
$989.50M |
|
$-207.50M |
|
$-734.80M |
|
$567.50M |
|
$607.30M |
|
$39.80M |
|
$170.40M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.47 |
|
-- |
|
-- |
|
0.37 |
|
1.16 |
|
60.46% |
|
14.88% |
|
14.88% |
|
EBITDA Margin |
20.28% |
17.58% |
|
14.29% |
|
$630.70M |
|
-- |
|
-- |
|
-- |
|
0.62 |
|
2.94 |
|
4.01 |
|
91.02 |
|
27.40% |
|
29.15% |
|
8.89% |
|
17.25% |
|
$5.38 |
|
$1.53 |
|
$2.40 |